Mercury Laboratories Balance Sheet Annual

Trade

BSE: 538964 | NSE: - | ISIN: INE947G01011 | Sector: Biotechnology & Drugs

921.65 +9.65 (1.06%)Updated : 27 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash	3.29	3.71	4.11	3.03
Cash Equivalents	4.93	3.61	2.82	1.84
Short Term Investments	0.22	0.57	0.03	0.01
Cashand Short Term Investments	8.44	7.88	6.96	4.88
Accounts Receivable- Trade Net	21.85	21.37	16.75	22.54
Total Receivables Net	21.85	21.37	17.23	23.01
Total Inventory	6.21	6.90	6.78	5.16
Other Current Assets Total	3.34	5.56	4.25	4.75
Total Current Assets	39.84	41.71	35.22	37.80
Property/ Plant/ Equipment Total- Net	27.82	24.35	25.76	26.27
Intangibles Net	0.03	0.04	0.06	0.08
Long Term Investments	0.01	0.01	0.01	0.01
Other Long Term Assets Total	0.27	1.47	1.39	1.21
Total Assets	67.96	67.58	62.43	65.37
Accounts Payable	5.18	6.38	6.87	11.78
Notes Payable/ Short Term Debt	2.63	2.94	2.66	0.00
Current Portof LT Debt/ Capital Leases	0.01	0.43	0.43	0.86
Other Currentliabilities Total	5.13	6.68	5.47	6.20
Total Current Liabilities	12.94	16.43	15.42	18.83
Long Term Debt	2.86	2.42	2.49	6.24
Capital Lease Obligations	0.05	0.04	0.42	-
Total Long Term Debt	2.92	2.47	2.90	6.24
Total Debt	5.55	5.83	5.99	7.10
Deferred Income Tax	1.26	1.89	2.23	2.13
Other Liabilities Total	0.00	1.16	1.54	1.27
Total Liabilities	17.12	21.95	22.09	28.48
Common Stock Total	1.20	1.20	1.20	1.20
Retained Earnings( Accumulated Deficit)	49.64	44.43	39.14	35.69
Total Equity	50.84	45.63	40.34	36.89
Total Liabilities Shareholders' Equity	67.96	67.58	62.43	65.37
Total Common Shares Outstanding	0.12	0.12	0.12	0.12
Tangible Book Valueper Share Common Eq	423.44	379.90	335.71	306.76